| pioglitazone / Generic mfg. |
NCT00719381: Effect of Pioglitazone on Inflammation in Cystic Fibrosis |
|
|
| Completed | 1 | 24 | US | Pioglitazone, Actos | Paul Beringer | Cystic Fibrosis | 06/09 | 06/09 | | |
NCT01489943: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects |
|
|
| Completed | 1 | 24 | US | GSK1605786 500 mg, Midazolam 3 mg, Pioglitazone 15 mg, Omeprazole 40 mg, Rosuvastatin 10 mg | GlaxoSmithKline | Crohn's Disease | 11/11 | 11/11 | | |
NCT00867126: Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine |
|
|
| Terminated | 1 | 6 | US | pioglitazone hydrochloride, laboratory biomarker analysis, questionnaire administration, quality-of-life assessment | University of Texas Southwestern Medical Center | Pancreatic Cancer | 02/12 | 02/12 | | |
NCT01431521: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) |
|
|
| Completed | 1 | 31 | NA | MK-4074 200 mg, Placebo for MK-4074, Pioglitazone hydrochloride 30 mg, Placebo for pioglitazone hydrochloride | Merck Sharp & Dohme LLC | Non-alcoholic Fatty Liver Disease | 09/12 | 10/12 | | |
NCT01454336: Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone |
|
|
| Completed | 1 | 3 | RoW | Cell injection | Royan Institute | Liver Fibrosis | 07/13 | 07/13 | | |
